HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoru Hosokawa Selected Research

Satoru Hosokawa Research Topics

Disease

4Neoplasms (Cancer)
10/2015 - 06/2011
2Colitis
10/2015 - 04/2015
2Adenocarcinoma
04/2015 - 11/2011
2Hypertrophy
02/2011 - 01/2009
1Ganglion Cysts (Ganglion)
01/2019
1Infections
01/2016
1Malaria
01/2016
1Adenoma (Adenomas)
04/2015
1Hyperplasia
12/2014
1Inflammation (Inflammations)
11/2011
1Breast Neoplasms (Breast Cancer)
06/2011

Drug/Important Bio-Agent (IBA)

3Dextran SulfateIBA
10/2015 - 11/2011
3Benzo(a)pyreneIBA
10/2015 - 11/2011
2CateninsIBA
10/2015 - 04/2015
2Drinking WaterIBA
04/2015 - 11/2011
1N-Methylaspartate (NMDA)IBA
01/2019
1Retinaldehyde (Retinal)IBA
01/2019
1Pharmaceutical PreparationsIBA
01/2016
1hemozoinIBA
01/2016
1InterferonsIBA
10/2015
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2015
1Proteins (Proteins, Gene)FDA Link
10/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2014
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2014
1MutagensIBA
11/2011
1CarcinogensIBA
11/2011
1acivicin (AT 125)IBA
11/2011
1Antineoplastic Agents (Antineoplastics)IBA
06/2011
1eribulinFDA Link
06/2011
1Biological ProductsIBA
06/2011
1halichondrin BIBA
06/2011
1methyl cellosolve (ethylene glycol monomethyl ether)IBA
02/2011
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2009

Therapy/Procedure

1Aftercare (After-Treatment)
10/2015
1Oral Administration
11/2011
1Drug Therapy (Chemotherapy)
06/2011